Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Xie H 

PROVIDER: S-EPMC5750158 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature